Parkinson'
Conditions
Interventions
None listed
Sponsors
Tohoku University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients with a clinical diagnosis or confirmed by previous clinical or genetic diagnosis that they have the target disease diagnosed at Tohoku University, Chiba Children's Hospital, Chiba Cancer Center, Konan Hospital, Juntendo University Hospital, Saitama Medical University Hospital, Nagasaki University Hospital, and National Cardiovascular Center are eligible.
Exclusion criteria
Exclusion criteria: Patients will be excluded from the study if consent from the patient or the patient's family cannot be obtained.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| We will analyze the clinical data of the patients and basic information of the healthy subjects, whole genome analysis, epigenome analysis, transcriptome analysis, metabolome analysis of various metabolites, fecal culture and metagenome analysis, metatranscriptome analysis, and proteome analysis of the collected specimens. | — |
Secondary
| Measure | Time frame |
|---|---|
| Patient and healthy subject data will be compared with Tohoku Medical Megabank Organization data (three-generation cohort and enterobacterial cohort). | — |
Countries
Japan
Contacts
Public ContactTakaaki Abe
Tohoku Univerisity, Graduate School of Biobedical Engineering Division of Medical Science
Outcome results
None listed